Administration Updates / Coronavirus / Safety & Health

FDA Approves First Treatment for COVID-19

covid-19The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Veklury is the first treatment for COVID-19 to receive FDA approval.

You can read more from the FDA here.

If You Enjoy Articles Like This - Subscribe to the AMAC Daily Newsletter
and Download the AMAC News App

Sign Up Today Download

If You Enjoy Articles Like This - Subscribe to the AMAC Daily Newsletter!

Notify of
Oldest Most Voted
Inline Feedbacks
View all comments
Gerold Martin
1 year ago

If AMAC ACTION wants to do something useful…urge Congress to hold hearings on COVID-19 response treatments, or rather THE LACK OF TREATMENTS. While the FDA and CDC ignore HCQ and Ivermectin which are highly effective in EARLY treatment around the world (CHEAP AND READILY AVAILABLE), the FDA approves REMDESIVIR, which is expensive and requires hospital stay. Note – The WHO immediately stated REM is ineffective.
=FDA claimes the “SIDE EFFECTS” of HCQ is too dangerous, while other drugs appproved by the FDA has disclaimers “MAY CAUSE DEATH”, as advertised on TV.

1 year ago

This is a good start, but I thought Rem was looking good about 3-4 months ago. How about Hydroxycloroquine , is that still possible for some people?
and then the one that Trump got at Walter Reed hospital, Trump said he was going to give this free to all Americans. But, remember all of these are reactive & what is needed is someone to come up with Pro-active treatment that will kick butt & stop Covid. A vaccine will be pro-active if it prevents the healthy from getting infected, so that must be the answer at this time.

Would love your thoughts, please comment.x